Goodwin (JD Supra France)

5 results for Goodwin (JD Supra France)

  • COVID-19: Measures to Support the French Economy

    The various thematic memos included below summarize the exceptional package enacted by the French State since the beginning of the lockdown (confinement) and aimed at supporting companies particularly affected by the economic and social consequences of the COVID-19 crisis. These measures are intended, in particular, to preserve the cash flows of companies whose business is adversely impacted...

  • COVID 19: Measures to Support the French Economy

    The various thematic memos included below summarize the exceptional package enacted by the French State since the beginning of the lockdown (confinement) and aimed at supporting companies particularly affected by the economic and social consequences of the COVID-19 crisis. These measures are intended, in particular, to preserve the cash flows of companies whose business is adversely impacted...

  • French Privacy Regulator Imposes Record Fine on Google for GDPR Violations

    On January 21, 2019, France’s data protection regulator (CNIL) imposed a €50 million fine on Google for violating core provisions of the European Union General Data Protection Regulation (GDPR). The action was initiated by two nonprofits on behalf of nearly 10,000 individuals. Google has announced that it will appeal the decision before the French Council of State.

  • New France-Luxembourg Double Taxation Treaty

    A new double taxation treaty between France and Luxembourg was signed on 20 March 2018 (the “New Treaty”). This New Treaty will replace the current tax treaty dated 1 April 1958, as amended several times and for the last time on 5 September 2014 (the “Current Treaty”). The New Treaty includes significant changes compared to the Current Treaty. This alert does not provide an exhaustive review...

  • France Aims for 80% Biosimilar Penetration by 2022

    In its 2018-2022 National Health Strategy, France aims for 80% biosimilar penetration by 2022, an increase from last year’s 70% target. France’s support for biosimilars is not new.

  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT